AgPlenus Ltd Appoints Dr. Dan Jacob Gelvan as New CEO

Share This Article

AgPlenus Ltd, a renowned global leader in pioneering sustainable crop protection products and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), is thrilled to announce the appointment of Dr. Dan Jacob Gelvan as its latest Chief Executive Officer, effective February 19, 2024. Dr. Gelvan brings over thirty years of extensive expertise in leading science and technology firms across the pharmaceutical, biotech, and healthcare sectors. His exceptional leadership and strategic foresight, demonstrated from pre-clinical stages to product launches, underscore his profound skills in multicultural management. Concurrent with Dr. Gelvan’s appointment, Dr. Brian Ember, AgPlenus’ current CEO, will transition to the role of Chief Business Officer, leveraging his invaluable contributions to AgPlenus’ growth to foster strategic partnerships and drive business expansion. Ofer Haviv, CEO of Evogene and chairman of AgPlenus, expressed his enthusiasm for Dr. Gelvan’s arrival, affirming his confidence in Dr. Gelvan’s capability to guide AgPlenus through its next phase of growth and innovation. Dr. Gelvan expressed his eagerness for the new role, emphasizing his commitment to revolutionizing agriculture through sustainable crop protection solutions and creating value for stakeholders in collaboration with AgPlenus’ talented team.

Read The Full Article here –